CFH and age-related macular degeneration: Although the precise mechanism through which the CFH Y402H variant confers an increased risk of AMD remains unclear, in vitro studies have shown that the at-risk CFH Y402H variant leads to the dysregulation of the complement pathway, with increased levels of the C3 protein [16].